Biosof develops, commercializes and markets bioinformtatics solutions for the annotation, analysis and curation of genomic data. Our solutions help genomics and proteomics researchers in the biopharma industry and in academia leverage computational power to discover new drug leads, verify lab experiments and cut significant research time. Biosof currently holds distribution licenses to research-enabling technology from several institutions including Columbia University, Technische Universität München and Tel Aviv Univeristy.